ChAd155-RSV vaccine is immunogenic and efficacious against bovine RSV infection-induced disease in young calves

Respiratory syncytial virus (RSV) infection causes a substantial lower-respiratory-tract disease burden in infants, constituting a global priority for vaccine development. We evaluated immunogenicity, safety and efficacy of a chimpanzee adenovirus (ChAd)-based vaccine candidate, ChAd155-RSV, in a bo...

Descripción completa

Detalles Bibliográficos
Autores principales: de Jong, Rineke, Stockhofe-Zurwieden, Norbert, Bonsing, Judith, Wang, Kai-Fen, Vandepaer, Sarah, Bouzya, Badiaa, Toussaint, Jean-François, Dieussaert, Ilse, Song, Haifeng, Steff, Ann-Muriel
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9575635/
https://www.ncbi.nlm.nih.gov/pubmed/36253363
http://dx.doi.org/10.1038/s41467-022-33649-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9575635/
https://www.ncbi.nlm.nih.gov/pubmed/36253363
http://dx.doi.org/10.1038/s41467-022-33649-3

Ejemplares similares